Education
About Us
Working with TipRanks
Follow Us
Jared Kelly Insider Profile
4 Followers
Jared Kelly, Chief Executive Officer at Oncolytics Biotech, holds 73.90K shares in Oncolytics Biotech (Ticker: ONCY). Most recently, Jared Kelly Bought 23,500 shares of Oncolytics Biotech on Aug 13, 2025 for an estimated value of $20.28K.
Jared Kelly Oncolytics Biotech (ONCY)Chief Executive Officer
Oncolytics Biotech (ONCY)
Chief Executive Officer
Ranked #41,202 out of 103,606 Corporate Insiders
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+20.10%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chief Executive Officer
Roles that Jared Kelly holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jared Kelly
Jared Kelly's Trading History
List of latest transactions for each holding click on a transaction to see Jared Kelly's performance on stock
You May Also Like
Jared Kelly insider profile FAQ
What is the percentage of profitable transactions made by Jared Kelly?
The percentage of profitable transactions made by Jared Kelly is 100%.
What is the average return per transaction made by Jared Kelly?
The average return per transaction made by Jared Kelly is 20.10%.
What stocks does Jared Kelly hold?
Jared Kelly holds: ONCY stocks.
What was Jared Kelly’s latest transaction?
Jared Kelly latest transaction was an Informative Buy of $20.28K.
What was Jared Kelly's most profitable transaction?
Jared Kelly’s most profitable transaction was an Informative Buy of ONCY stock on August 13, 2025. The return on the trade was 33.30%.
What is Jared Kelly's role in Oncolytics Biotech?
Jared Kelly's role in Oncolytics Biotech is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.